Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
Supports aldosterone antagonist use beyond BP control; leaves open prospective validation of remodeling benefits.
Al‐Hashedi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: